Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
David Eugenio Hinojosa-González, Daniel Dávila-González, Gustavo Salgado-Garza, Eduardo Flores-VillalbaLung India 2020 37(3):252-256
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of surfactant-like lipoprotein material within distal bronchioles and alveoli due to impaired clearance. Clinically, PAP presents with dyspnea and cough. A 58-year-old Hispanic man presented with 6 months of productive cough, weight loss, and progressively worsening dyspnea. He reported a long history of poorly controlled type 2 diabetes that led to diabetic nephropathy. The patient had a strong passive smoking history for over 30 years and exposure to woodsmoke. He had pulmonary tuberculosis in 2007 and 2012. In 2011, he was diagnosed with renal failure, was dialyzed for a year, and received a renal transplant in 2012. His posttransplant medication regimens included tacrolimus, mycophenolic acid, and prednisone. Six months after the transplant, he suffered graft rejection, managed with steroids and switching from tacrolimus to sirolimus. His physical examination demonstrated scattered inspiratory crackles, and a chest X-ray showed bilateral perihilar ground-glass opacities. PAP was diagnosed through lung biopsy, which showed eosinophilic granular infiltrate withing the alveoli. Sirolimus was switched back to tacrolimus 2 mg in September 2018. PAP diagnosis included hematoxylin and eosin and PAS. Clinical follow-up included oxygen saturatio...
Source: Lung India - Category: Respiratory Medicine Authors: David Eugenio Hinojosa-Gonz & #225;lez Daniel D & #225;vila-Gonz & #225;lez Gustavo Salgado-Garza Eduardo Flores-Villalba Source Type: research
More News: Cough | Diabetes | Diabetes Type 2 | Endocrinology | India Health | Lung Transplant | Prednisone | Prograf | Renal Failure | Respiratory Medicine | Smokers | Tacrolimus | Transplant Surgery | Transplants | Tuberculosis | Weight Loss | X-Ray